Clinical Trial

STRIVE Post-Market Registry Study

Recruiting
View on ClinicalTrials.gov →
Summary
This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2020-03-09; most recent amendment 2026-04-23.
Status change: Not Yet Recruiting → Recruiting 2021-09-23
Status change: Enrolling by Invitation → Not Yet Recruiting 2020-03-30
Trial Details
NCT Number NCT04302272
Lead Sponsor Olympus Corporation of the Americas
Conditions Emphysema
Enrollment 150 participants
Start Date 2021-10-09
Primary Completion 2026-12 (estimated)
Study Completion 2029-10 (estimated)
Updated on ClinicalTrials.gov 2026-08-03